Immix Biopharma Statistics
NASDAQ: IMMXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
9.49-0.15 (-1.56%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Pre-market: 9.36 -1.37%
Immix Biopharma by the numbers
Immix Biopharma has a market capitalization of $786.7 million based on 82.90M shares outstanding. With trailing EPS of $-0.88, Immix Biopharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 18.6% below its 50-day average and 3.3% above its 200-day average.
Average daily trading volume is 1.66M shares, or about $15.8 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
IMMX valuation vs. peer median
| Metric | IMMX | Peer median | Difference |
|---|---|---|---|
| Market cap | $786.75M | $789.00M | -0% |
| Avg. volume | 1.66M | 2.34M | -29% |
Peer median across 8 companies: IVA, LXRX, OBX, GERN, HELP, AVBP, ANNX, ARDX.
Valuation
- Market cap
- $786.75M
- EPS (TTM)
- $-0.88
- Shares outstanding
- 82.90M
Price and trading
- Previous close
- 9.64
- Open
- 9.50
- Day range
- 9.40 – 9.69
- 52-week range
- 2.31 – 15.10
- 52-week change
- +278.09%
- Beta
- —
- Volume
- 1.38M
- Average volume
- 1.66M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 6, 2026
Additional statistics
- Market Cap
- 786.75M
- Forward Pe
- -11.20
- Eps
- -0.88
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 15.10
- Week52 Low
- 2.31
- Avg Volume
- 1.66M
- Shares Outstanding
- 82.90M
- Ma50
- 11.65
- Ma200
- 9.19
- Earnings Date
- Nov 6, 2026
- Pct From52w High
- -37.15%
- Pct From52w Low
- 310.82%